Top Markets
#1 0G 0G +40.03%
#2 Merlin's Seal BTC Merlin's Seal BTC +37.89%
#3 Useless Coin Useless Coin +34.52%
#4 StonkBroker StonkBroker +33.91%
#5 SAFEcoin SAFEcoin +29.22%
#6 Arbitrum Arbitrum +28.52%
#7 Notcoin Notcoin +18.52%
#8 Full Moon Full Moon +18.20%
#9 Zora Zora +16.54%
#10 Curve DAO Curve DAO +16.02%
Coin of the day
0G 0G
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Evommune, Inc. Evommune, Inc.

Evommune, Inc.

EVMN
Rang in aandelen #13821
Evommune, Inc. is a United States-based clinical-stage biotechnology company... Evommune, Inc. is a United States-based clinical-stage biotechnology company dedicated to advancing novel therapeutic solutions. Their primary focus lies in addressing the underlying mechanisms of chronic inflammatory diseases. Initial clinical development efforts are concentrated on conditions such as chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. The company's investigational portfolio features EVO756, which is being developed for the treatment of chronic spontaneous urticaria (CSU) and atopic dermatitis (AD), and EVO301, intended for atopic dermatitis (AD) and ulcerative colitis (UC). Established in 2020, Evommune operates from its headquarters in Palo Alto, California.
Aandeelprijs
$12.63
Marktkapitalisatie
$458.19M
Verandering (1 dag)
-3.26%
Verandering (1 jaar)
-
Land
US
Handel Evommune, Inc. (EVMN)

Categorie

Healthcare
EPS voor Evommune, Inc. (EVMN)
EPS per 2026 TTM: 0
Volgens de laatste financiële rapporten en de aandelenkoers van Evommune, Inc. is de huidige EPS van het bedrijf (TTM) 0. Eind 2026 had het bedrijf een EPS van 0, gelijk aan de EPS van 2026 die 0 bedroeg.
EPS-geschiedenis van Evommune, Inc. van 2026 tot 2026
EPS aan het einde van elk jaar
Jaar EPS Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
EPS van vergelijkbare bedrijven of concurrenten
Bedrijf EPS EPS-verschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH